The startup develops a biotechnology device specifically designed for ostomy patients, enabling self-management without the need for additional surgical procedures. This device offers features such as auto-replaceability, enhancing patient comfort and improving daily life quality.
Funding
$690K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Ostomy patients often face challenges in managing their condition, requiring frequent appliance replacements and potentially leading to discomfort and reduced quality of life. Current solutions may involve additional surgical procedures or complex maintenance routines, adding to the burden on patients.
Solution
Ownmed Innovation is developing Ostofix, an anti-reflux medical device designed to simplify ostomy self-care and improve the quality of life for ostomized individuals. Ostofix aims to provide greater control and independence in managing bodily waste, reducing the need for frequent appliance replacements. The device is designed for self-management, potentially eliminating the need for additional surgical interventions. By offering an advanced solution, Ownmed Innovation empowers patients to manage their condition more effectively and comfortably, enhancing their daily lives.
Target Audience
The primary target audience includes ostomy patients seeking a more convenient and comfortable solution for managing their condition, as well as healthcare professionals involved in ostomy care.
Features
- Anti-reflux technology to prevent leakage and maintain hygiene
- Self-replaceable design for easy and independent management
- Intended to reduce the frequency of appliance replacements
- Designed to improve patient comfort and overall quality of life